Clinical trial
The PIRATE PROJECT: a Point-of-care, Informatics-based Randomized Controlled Trial for Decreasing Over-utilization of Antibiotic ThErapy in Gram-negative Bacteremia
NCT03101072 is registered in ClinicalTrials.gov with University of Geneva, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The PIRATE PROJECT: a Point-of-care, Informatics-based Randomized Controlled Trial for Decreasing Over-utilization of Antibiotic ThErapy in Gram-negative Bacteremia
- Lead sponsor
- University of Geneva, Switzerland
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 27, 2017
- Completion date
- August 26, 2019
- Enrollment
- 504 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
bacteraemia caused by gram-negative bacteria